Your browser doesn't support javascript.
loading
Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition.
Sun, Michel M; Levinson, Ralph D; Filipowicz, Artur; Anesi, Stephen; Kaplan, Henry J; Wang, Wei; Goldstein, Debra A; Gangaputra, Sapna; Swan, Robert T; Sen, H Nida; Gordon, Lynn K.
Afiliación
  • Sun MM; Department of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA.
  • Levinson RD; Department of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA.
  • Filipowicz A; Department of Ophthalmology, Massachusetts Eye Research and Surgical Institution, Waltham, MA, USA.
  • Anesi S; Department of Ophthalmology, Massachusetts Eye Research and Surgical Institution, Waltham, MA, USA.
  • Kaplan HJ; Department of Ophthalmology, University of Louisville, Louisville, KY, USA.
  • Wang W; Department of Ophthalmology, University of Louisville, Louisville, KY, USA.
  • Goldstein DA; Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Gangaputra S; Department of Ophthalmology, Vanderbilt Eye Institute, Nashville, TN, USA.
  • Swan RT; Department of Ophthalmology, SUNY Upstate Medical University, Syracuse, NY, USA.
  • Sen HN; National Eye Institute, NIH, Bethesda, MD, USA.
  • Gordon LK; Department of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA.
Ocul Immunol Inflamm ; 28(2): 217-227, 2020.
Article en En | MEDLINE | ID: mdl-30821569

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Uveítis / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Ocul Immunol Inflamm Asunto de la revista: ALERGIA E IMUNOLOGIA / OFTALMOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Uveítis / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Ocul Immunol Inflamm Asunto de la revista: ALERGIA E IMUNOLOGIA / OFTALMOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos